Anti-FABP4 antibody (1-132 aa) [SMM] (STJ11106996)

SKU:
STJ11106996

Current Stock:
Host: Mouse
Applications: WB/ELISA
Reactivity: Human/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Monoclonal
Clone ID: SMM
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:1000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: FABP4
Gene ID: 2167
Uniprot ID: FABP4_HUMAN
Immunogen Region: 1-132 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 1-132 of human FABP4 (NP_001433.1)
Immunogen Sequence: MCDAFVGTWKLVSSENFDDY MKEVGVGFATRKVAGMAKPN MIISVNGDVITIKSESTFKN TEISFILGQEFDEVTADDRK VKSTITLDGGVLVHVQKWDG KSTTIKRKREDDKLVVECVM KGVTSTRVYERA
Function Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid. Delivers long-chain fatty acids and retinoic acid to their cognate receptors in the nucleus.
Protein Name Fatty Acid-Binding Protein - Adipocyte
Adipocyte Lipid-Binding Protein
Albp
Adipocyte-Type Fatty Acid-Binding Protein
A-Fabp
Afabp
Fatty Acid-Binding Protein 4
Database Links Reactome: R-HSA-163560
Reactome: R-HSA-381340
Cellular Localisation Cytoplasm
Nucleus
Depending On The Nature Of The Ligand
A Conformation Change Exposes A Nuclear Localization Motif And The Protein Is Transported Into The Nucleus
Subject To Constitutive Nuclear Export
Alternative Antibody Names Anti-Fatty Acid-Binding Protein - Adipocyte antibody
Anti-Adipocyte Lipid-Binding Protein antibody
Anti-Albp antibody
Anti-Adipocyte-Type Fatty Acid-Binding Protein antibody
Anti-A-Fabp antibody
Anti-Afabp antibody
Anti-Fatty Acid-Binding Protein 4 antibody
Anti-FABP4 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance